Articles
Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence
- Journal/Conference:
- Lung Cancer
- Author(s):
- Ernest Nadal 1, Nada Rifi 2, Sarah Kane 3, Sokhna Mbacke 3, Lindsey Starkman 3, Beatrice Suero 3, Hannah Le 2, Imtiaz A Samjoo
- Publication Date:
- 2024
- Topic/Therapeutic Area:
- Oncology, Respiratory
- Condition:
- Lung Cancer
Artificial Intelligence in Real-World Evidence Generation: Systematic Review of Applications and Challenges
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Verma A1, Patel N1, Krishna A1, Pruthi J1, Rai MK2, Prasanna R | 1 1EVERSANA, Mumbai, India, 2EVERSANA, Singapore, Singapore
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Other
The Effectiveness of Telemedicine in Improving Access to Healthcare Services: A Systematic Review
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Jangid S1, Vishnubhotla M2, Prasanna R3, Rai MK3 | 1EVERSANA, Mumbai, MH, India, 2Eversana, HYDERABAD, Telangana, India, 3EVERSANA, Singapore, Singapore
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Other
Cost-Effectiveness Analysis of 1.5% Ruxolitinib Cream for the Treatment of Patients With Atopic Dermatitis in Canada
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Pastor L1, Hughes-Martin A1, Cameron H1, Marino R2, Larbi M3 1EVERSANA, Burlington, ON, Canada, 2Incyte Corporation, Wilmington, DE, USA, 3Incyte Biosciences Canada, Pointe Claire, QC, Canada
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Immunology
- Condition:
- Atopic Dermatitis
Role of Health-Economics Application in Enhancing Personalized Medicine: A Comprehensive Systematic Review
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Jangid S1, Verma A1, Krishna A1, Pruthi J1, Prasanna R1, Rai MK2 | 1EVERSANA, Mumbai, MH, India, 2EVERSANA, Singapore, Singapore
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Other
A Literature Review to Identify Prognostic Factors and Treatment Effect Modifiers in Population-Adjusted Indirect Comparisons for Multiple Myeloma
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Chiang K1, He J2, Kwong WJ2, Lin X2, Yang L2, Keng MJ3, Nair S3, Hashim M4, Samjoo I | 1 1EVERSANA, Burlington, ON, Canada, 2Janssen Global Services, Raritan, NJ, USA, 3Janssen Pharmaceutica NV, Beerse, Belgium, 4Janssen Pharmaceutica NV, Rotterdam, ZH, Netherlands
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Hematology, Oncology
- Condition:
- Relapsed or Refractory Multiple Myeloma
Health Economics Studies Assessment of the 2ND China Rare Disease Catalogue: A Scoping Review
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Fang J1, Du H1, Tjong A Hung I1, Rai MK2, Cameron C3 | 1EVERSANA (Shanghai) Consulting Co., Ltd., Shanghai, China, 2EVERSANA, Singapore, Singapore, 3EVERSANA, Sydney , NS, Canada
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Rare Disease
- Condition:
- Rare and Orphan Diseases
CAR-T Cell Therapy Accessibility: A Targeted Review of Access Challenges and Opportunities in APAC Region
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Krishna A1, Verma A1, Pruthi J1, Prasanna R1, Rai MK2 | 1EVERSANA, Mumbai, MH, India, 2EVERSANA, Singapore, Singapore
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Hematology, Oncology
- Condition:
- Cancer
Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Udeze C1, Gargano M1, Kaindl L2, Kane S2, Zhou A2, Jain S1, Lopez A | 1 1Vertex Pharmaceuticals Incorporated, Boston, MA, USA, 2Eversana, Burlington, ON, Canada
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Hematology, Oncology
- Condition:
- Rare and Orphan Diseases
Budget Impact Analyses of Hemoglobin a1C and Lipid Panel Point-of-Care Testing With Afinion™ 2 in Italy and Canada
- Journal/Conference:
- 2024-11, ISPOR Europe 2024, Barcelona, Spain
- Author(s):
- Garcia D1, Ruffolo A2, Walczyk Mooradally A3, Zhou A1, Lazaridis E4, Laurelli B5 | 1EVERSANA, Burlington, ON, Canada, 2Abbott Rapid Diagnostics, Köln, NW, Germany, 3EVERSANA, Waterdown, ON, Canada, 4Abbott Rapid Diagnostics, Ottawa, ON, Canada, 5Abbott Rapid Diagnostics, Sesto San Giovanni, MI, Italy
- Publication Date:
- Value in Health, Volume 27, Issue 12, S2 (December 2024)
- Topic/Therapeutic Area:
- Metabolic
- Condition:
- Diabetes/Endocrine/Metabolic Disorders